Global Dry Age-Related Macular Degeneration Market Research Report 2025(Status and Outlook)

March 2025 | 227 pages | ID: GDD1E8C7785DEN
Bosson Research

Abstracts

Report Overview

Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.

This report provides a deep insight into the global Dry Age-Related Macular Degeneration market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dry Age-Related Macular Degeneration Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dry Age-Related Macular Degeneration market in any manner.

Global Dry Age-Related Macular Degeneration Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Santen Pharmaceuticals

Allergan

Bausch Health

Alimera Science

Phio Pharmaceuticals

Ocumension Therapeutics

Belite Bio

Kubota Vision

Iveric Bio

Eyestem Research

Y2 Solution

Stealth Biotherapeutics

Market Segmentation (by Type)

Oral

Injectables

Market Segmentation (by Application)

Above 40 Years

Above 60 Years

Above 75 Years

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Dry Age-Related Macular Degeneration Market
• Overview of the regional outlook of the Dry Age-Related Macular Degeneration Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dry Age-Related Macular Degeneration Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Dry Age-Related Macular Degeneration
1.2 Key Market Segments
1.2.1 Dry Age-Related Macular Degeneration Segment by Type
1.2.2 Dry Age-Related Macular Degeneration Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Dry Age-Related Macular Degeneration Market Overview
2.1 Global Market Overview
2.1.1 Global Dry Age-Related Macular Degeneration Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Dry Age-Related Macular Degeneration Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Dry Age-Related Macular Degeneration Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Dry Age-Related Macular Degeneration Product Life Cycle
3.3 Global Dry Age-Related Macular Degeneration Sales by Manufacturers (2020-2025)
3.4 Global Dry Age-Related Macular Degeneration Revenue Market Share by Manufacturers (2020-2025)
3.5 Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Dry Age-Related Macular Degeneration Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Dry Age-Related Macular Degeneration Manufacturing Sites, Area Served, Product Type
3.8 Dry Age-Related Macular Degeneration Market Competitive Situation and Trends
3.8.1 Dry Age-Related Macular Degeneration Market Concentration Rate
3.8.2 Global 5 and 10 Largest Dry Age-Related Macular Degeneration Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Dry Age-Related Macular Degeneration Industry Chain Analysis
4.1 Dry Age-Related Macular Degeneration Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Dry Age-Related Macular Degeneration Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Dry Age-Related Macular Degeneration Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Dry Age-Related Macular Degeneration Market
5.7 ESG Ratings of Leading Companies
6 Global Dry Age-Related Macular Degeneration Market by Region
6.1 Global Dry Age-Related Macular Degeneration Market Size by Region
6.1.1 Global Dry Age-Related Macular Degeneration Market Size by Region
6.1.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Region
6.2 Global Dry Age-Related Macular Degeneration Sales by Region
6.2.1 Global Dry Age-Related Macular Degeneration Sales by Region
6.2.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Region
7 North America Market Overview
7.1 North America Dry Age-Related Macular Degeneration Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Dry Age-Related Macular Degeneration Market Size by Type
7.3 North America Dry Age-Related Macular Degeneration Market Size by Application
8 Europe Market Overview
8.1 Europe Dry Age-Related Macular Degeneration Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Dry Age-Related Macular Degeneration Market Size by Type
8.3 Europe Dry Age-Related Macular Degeneration Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Type
9.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Application
10 South America Market Overview
10.1 South America Dry Age-Related Macular Degeneration Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Dry Age-Related Macular Degeneration Market Size by Type
10.3 South America Dry Age-Related Macular Degeneration Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Type
11.3 Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Application
12 Dry Age-Related Macular Degeneration Market Production by Region
12.1 Global Production of Dry Age-Related Macular Degeneration by Region(2020-2025)
12.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Region (2020-2025)
12.3 Global Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Dry Age-Related Macular Degeneration Production
12.4.1 North America Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
12.4.2 North America Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Dry Age-Related Macular Degeneration Production
12.5.1 Europe Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
12.5.2 Europe Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Dry Age-Related Macular Degeneration Production (2020-2025)
12.6.1 Japan Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
12.6.2 Japan Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Dry Age-Related Macular Degeneration Production (2020-2025)
12.7.1 China Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
12.7.2 China Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
13 Dry Age-Related Macular Degeneration Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2020-2033)
13.3 Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2020-2033)
13.4 Global Dry Age-Related Macular Degeneration Price by Type (2020-2033)
14 Dry Age-Related Macular Degeneration Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Dry Age-Related Macular Degeneration Market Sales by Application (2020-2033)
14.3 Global Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2020-2033)
14.4 Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Santen Pharmaceuticals
15.1.1 Santen Pharmaceuticals Basic Information
15.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
15.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
15.1.4 Santen Pharmaceuticals Business Overview
15.1.5 Santen Pharmaceuticals SWOT Analysis
15.1.6 Santen Pharmaceuticals Recent Developments
15.2 Allergan
15.2.1 Allergan Basic Information
15.2.2 Allergan Dry Age-Related Macular Degeneration Product Overview
15.2.3 Allergan Dry Age-Related Macular Degeneration Product Market Performance
15.2.4 Allergan Business Overview
15.2.5 Allergan SWOT Analysis
15.2.6 Allergan Recent Developments
15.3 Bausch Health
15.3.1 Bausch Health Basic Information
15.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Overview
15.3.3 Bausch Health Dry Age-Related Macular Degeneration Product Market Performance
15.3.4 Bausch Health Business Overview
15.3.5 Bausch Health SWOT Analysis
15.3.6 Bausch Health Recent Developments
15.4 Alimera Science
15.4.1 Alimera Science Basic Information
15.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Overview
15.4.3 Alimera Science Dry Age-Related Macular Degeneration Product Market Performance
15.4.4 Alimera Science Business Overview
15.4.5 Alimera Science Recent Developments
15.5 Phio Pharmaceuticals
15.5.1 Phio Pharmaceuticals Basic Information
15.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
15.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
15.5.4 Phio Pharmaceuticals Business Overview
15.5.5 Phio Pharmaceuticals Recent Developments
15.6 Ocumension Therapeutics
15.6.1 Ocumension Therapeutics Basic Information
15.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
15.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Market Performance
15.6.4 Ocumension Therapeutics Business Overview
15.6.5 Ocumension Therapeutics Recent Developments
15.7 Belite Bio
15.7.1 Belite Bio Basic Information
15.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Overview
15.7.3 Belite Bio Dry Age-Related Macular Degeneration Product Market Performance
15.7.4 Belite Bio Business Overview
15.7.5 Belite Bio Recent Developments
15.8 Kubota Vision
15.8.1 Kubota Vision Basic Information
15.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Overview
15.8.3 Kubota Vision Dry Age-Related Macular Degeneration Product Market Performance
15.8.4 Kubota Vision Business Overview
15.8.5 Kubota Vision Recent Developments
15.9 Iveric Bio
15.9.1 Iveric Bio Basic Information
15.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Overview
15.9.3 Iveric Bio Dry Age-Related Macular Degeneration Product Market Performance
15.9.4 Iveric Bio Business Overview
15.9.5 Iveric Bio Recent Developments
15.10 Eyestem Research
15.10.1 Eyestem Research Basic Information
15.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Overview
15.10.3 Eyestem Research Dry Age-Related Macular Degeneration Product Market Performance
15.10.4 Eyestem Research Business Overview
15.10.5 Eyestem Research Recent Developments
15.11 Y2 Solution
15.11.1 Y2 Solution Basic Information
15.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Overview
15.11.3 Y2 Solution Dry Age-Related Macular Degeneration Product Market Performance
15.11.4 Y2 Solution Business Overview
15.11.5 Y2 Solution Recent Developments
15.12 Stealth Biotherapeutics
15.12.1 Stealth Biotherapeutics Basic Information
15.12.2 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
15.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Market Performance
15.12.4 Stealth Biotherapeutics Business Overview
15.12.5 Stealth Biotherapeutics Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 4. Global Dry Age-Related Macular Degeneration Market Size by Application (M USD)
Table 5. Dry Age-Related Macular Degeneration Market Size Comparison by Region (M USD)
Table 6. Global Dry Age-Related Macular Degeneration Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Dry Age-Related Macular Degeneration Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Dry Age-Related Macular Degeneration Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2024)
Table 11. Global Market Dry Age-Related Macular Degeneration Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Dry Age-Related Macular Degeneration Manufacturing Sites and Area Served
Table 13. Manufacturers Dry Age-Related Macular Degeneration Product Type
Table 14. Global Dry Age-Related Macular Degeneration Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Dry Age-Related Macular Degeneration Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Dry Age-Related Macular Degeneration Market Size Comparison by Region (M USD)
Table 26. Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2033) & (M USD)
Table 27. Global Dry Age-Related Macular Degeneration Market Size Market Share by Region (2020-2033)
Table 28. Global Dry Age-Related Macular Degeneration Sales by Region (2020-2033) & (K MT)
Table 29. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2020-2033)
Table 30. North America Dry Age-Related Macular Degeneration Market Size by Country (2020-2033) & (M USD)
Table 31. North America Dry Age-Related Macular Degeneration Sales by Country (2020-2033) & (K MT)
Table 32. North America Dry Age-Related Macular Degeneration Sales by Type (K MT)
Table 33. North America Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 34. North America Dry Age-Related Macular Degeneration Sales (K MT) by Type (2020-2033)
Table 35. North America Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2020-2033)
Table 36. North America Dry Age-Related Macular Degeneration Sales by Application (K MT)
Table 37. North America Dry Age-Related Macular Degeneration Market Size by Application (M USD)
Table 38. North America Dry Age-Related Macular Degeneration Sales (K MT) by Application (2020-2033)
Table 39. North America Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2020-2033)
Table 40. Europe Dry Age-Related Macular Degeneration Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Dry Age-Related Macular Degeneration Sales by Country (2020-2033) & (K MT)
Table 42. Europe Dry Age-Related Macular Degeneration Sales by Type (K MT)
Table 43. Europe Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 44. Europe Dry Age-Related Macular Degeneration Sales (K MT) by Type (2020-2033)
Table 45. Europe Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2020-2033)
Table 46. Europe Dry Age-Related Macular Degeneration Sales by Application (K MT)
Table 47. Europe Dry Age-Related Macular Degeneration Market Size by Application (M USD)
Table 48. Europe Dry Age-Related Macular Degeneration Sales (K MT) by Application (2020-2033)
Table 49. Europe Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Dry Age-Related Macular Degeneration Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Dry Age-Related Macular Degeneration Sales by Type (K MT)
Table 53. Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 54. Asia-Pacific Dry Age-Related Macular Degeneration Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Dry Age-Related Macular Degeneration Sales by Application (K MT)
Table 57. Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Application (M USD)
Table 58. Asia-Pacific Dry Age-Related Macular Degeneration Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2020-2025)
Table 60. South America Dry Age-Related Macular Degeneration Market Size by Country (2020-2033) & (M USD)
Table 61. South America Dry Age-Related Macular Degeneration Sales by Country (2020-2033) & (K MT)
Table 62. South America Dry Age-Related Macular Degeneration Sales by Type (K MT)
Table 63. South America Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 64. South America Dry Age-Related Macular Degeneration Sales (K MT) by Type (2020-2033)
Table 65. South America Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2020-2033)
Table 66. South America Dry Age-Related Macular Degeneration Sales by Application (K MT)
Table 67. South America Dry Age-Related Macular Degeneration Market Size by Application (M USD)
Table 68. South America Dry Age-Related Macular Degeneration Sales (K MT) by Application (2020-2033)
Table 69. South America Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Dry Age-Related Macular Degeneration Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Dry Age-Related Macular Degeneration Sales by Type (K MT)
Table 73. Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 74. Middle East and Africa Dry Age-Related Macular Degeneration Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Dry Age-Related Macular Degeneration Sales by Application (K MT)
Table 77. Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Application (M USD)
Table 78. Middle East and Africa Dry Age-Related Macular Degeneration Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2020-2033)
Table 80. Global Dry Age-Related Macular Degeneration Production (K MT) by Region(2020-2025)
Table 81. Global Dry Age-Related Macular Degeneration Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Dry Age-Related Macular Degeneration Revenue Market Share by Region (2020-2025)
Table 83. Global Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Dry Age-Related Macular Degeneration Sales by Type (K MT)
Table 89. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 90. Global Dry Age-Related Macular Degeneration Sales (K MT) by Type (2020-2033)
Table 91. Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2020-2033)
Table 92. Global Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2020-2033)
Table 93. Global Dry Age-Related Macular Degeneration Market Size Share by Type (2020-2033)
Table 94. Global Dry Age-Related Macular Degeneration Sales (K MT) by Application
Table 95. Global Dry Age-Related Macular Degeneration Market Size by Application(M USD)
Table 96. Global Dry Age-Related Macular Degeneration Sales by Application (2020-2033) & (K MT)
Table 97. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2020-2033)
Table 98. Global Dry Age-Related Macular Degeneration Market Size by Application (2020-2033) & (M USD)
Table 99. Global Dry Age-Related Macular Degeneration Market Share by Application (2020-2033)
Table 100. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2033)
Table 101. Santen Pharmaceuticals Basic Information
Table 102. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 103. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Santen Pharmaceuticals Business Overview
Table 105. Santen Pharmaceuticals SWOT Analysis
Table 106. Santen Pharmaceuticals Recent Developments
Table 107. Allergan Basic Information
Table 108. Allergan Dry Age-Related Macular Degeneration Product Overview
Table 109. Allergan Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Allergan Business Overview
Table 111. Allergan SWOT Analysis
Table 112. Allergan Recent Developments
Table 113. Bausch Health Basic Information
Table 114. Bausch Health Dry Age-Related Macular Degeneration Product Overview
Table 115. Bausch Health Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Bausch Health Business Overview
Table 117. Bausch Health SWOT Analysis
Table 118. Bausch Health Recent Developments
Table 119. Alimera Science Basic Information
Table 120. Alimera Science Dry Age-Related Macular Degeneration Product Overview
Table 121. Alimera Science Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Alimera Science Business Overview
Table 123. Alimera Science Recent Developments
Table 124. Phio Pharmaceuticals Basic Information
Table 125. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 126. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Phio Pharmaceuticals Business Overview
Table 128. Phio Pharmaceuticals Recent Developments
Table 129. Ocumension Therapeutics Basic Information
Table 130. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
Table 131. Ocumension Therapeutics Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Ocumension Therapeutics Business Overview
Table 133. Ocumension Therapeutics Recent Developments
Table 134. Belite Bio Basic Information
Table 135. Belite Bio Dry Age-Related Macular Degeneration Product Overview
Table 136. Belite Bio Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Belite Bio Business Overview
Table 138. Belite Bio Recent Developments
Table 139. Kubota Vision Basic Information
Table 140. Kubota Vision Dry Age-Related Macular Degeneration Product Overview
Table 141. Kubota Vision Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Kubota Vision Business Overview
Table 143. Kubota Vision Recent Developments
Table 144. Iveric Bio Basic Information
Table 145. Iveric Bio Dry Age-Related Macular Degeneration Product Overview
Table 146. Iveric Bio Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Iveric Bio Business Overview
Table 148. Iveric Bio Recent Developments
Table 149. Eyestem Research Basic Information
Table 150. Eyestem Research Dry Age-Related Macular Degeneration Product Overview
Table 151. Eyestem Research Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Eyestem Research Business Overview
Table 153. Eyestem Research Recent Developments
Table 154. Y2 Solution Basic Information
Table 155. Y2 Solution Dry Age-Related Macular Degeneration Product Overview
Table 156. Y2 Solution Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Y2 Solution Business Overview
Table 158. Y2 Solution Recent Developments
Table 159. Stealth Biotherapeutics Basic Information
Table 160. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
Table 161. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Stealth Biotherapeutics Business Overview
Table 163. Stealth Biotherapeutics Recent Developments
List of Figures
Figure 1. Product Picture of Dry Age-Related Macular Degeneration
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Dry Age-Related Macular Degeneration Market Size (M USD), 2024-2033
Figure 5. Global Dry Age-Related Macular Degeneration Market Size (M USD) (2020-2033)
Figure 6. Global Dry Age-Related Macular Degeneration Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Dry Age-Related Macular Degeneration Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Dry Age-Related Macular Degeneration Product Life Cycle
Figure 13. Dry Age-Related Macular Degeneration Sales Share by Manufacturers in 2024
Figure 14. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers in 2024
Figure 15. Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Dry Age-Related Macular Degeneration Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Dry Age-Related Macular Degeneration Revenue in 2024
Figure 18. Industry Chain Map of Dry Age-Related Macular Degeneration
Figure 19. Global Dry Age-Related Macular Degeneration Market PEST Analysis
Figure 20. Global Dry Age-Related Macular Degeneration Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Dry Age-Related Macular Degeneration Market Size by Region
Figure 27. Global Dry Age-Related Macular Degeneration Market Size Market Share by Region (2020-2033)
Figure 28. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Dry Age-Related Macular Degeneration Market Size (M USD) by Country
Figure 33. USA Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Dry Age-Related Macular Degeneration Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Dry Age-Related Macular Degeneration Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Dry Age-Related Macular Degeneration Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Dry Age-Related Macular Degeneration Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Dry Age-Related Macular Degeneration Market Size (M USD)by Type
Figure 40. North America Dry Age-Related Macular Degeneration Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Dry Age-Related Macular Degeneration Market Size (M USD) by Country
Figure 45. Germany Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Dry Age-Related Macular Degeneration Market Size (M USD) by Type
Figure 56. Europe Dry Age-Related Macular Degeneration Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Dry Age-Related Macular Degeneration Market Size (M USD) by Country
Figure 61. China Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Dry Age-Related Macular Degeneration Market Size (M USD) by Type
Figure 72. Asia-Pacific Dry Age-Related Macular Degeneration Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Dry Age-Related Macular Degeneration Market Size (M USD) by Country
Figure 77. Brazil Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Dry Age-Related Macular Degeneration Market Size (M USD) by Type
Figure 84. South America Dry Age-Related Macular Degeneration Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Dry Age-Related Macular Degeneration Market Size (M USD) by Country
Figure 89. Saudi Arabia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Dry Age-Related Macular Degeneration Market Size (M USD) by Type
Figure 100. Middle East and Africa Dry Age-Related Macular Degeneration Market Size (M USD) by Application
Figure 101. Global Dry Age-Related Macular Degeneration Production Market Share by Region (2020-2025)
Figure 102. North America Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 105. China Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Figure 108. Sales Market Share of Dry Age-Related Macular Degeneration by Type (2020-2033)
Figure 109. Sales Market Share of Dry Age-Related Macular Degeneration by Type in 2024
Figure 110. Market Size Share of Dry Age-Related Macular Degeneration by Type (2020-2033)
Figure 111. Market Size Share of Dry Age-Related Macular Degeneration by Type in 2024
Figure 112. Global Dry Age-Related Macular Degeneration Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Dry Age-Related Macular Degeneration Market Size by Application(M USD)
Figure 115. Global Dry Age-Related Macular Degeneration Market Share by Application
Figure 116. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2020-2033)
Figure 117. Global Dry Age-Related Macular Degeneration Sales Market Share by Application in 2024
Figure 118. Global Dry Age-Related Macular Degeneration Market Share by Application (2020-2033)
Figure 119. Global Dry Age-Related Macular Degeneration Market Share by Application in 2024
Figure 120. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2033)